光疗在银屑病中的应用：作用机制的综述。
Phototherapy in psoriasis: a review of mechanisms of action.
机构信息
Department of Dermatology, University of California, San Francisco, CA, USA.
出版信息
J Cutan Med Surg. 2013 Jan-Feb;17(1):6-12. doi: 10.2310/7750.2012.11124.
Abstract
BACKGROUND
Phototherapy is one of the most efficacious treatment options for psoriasis. New, emerging studies are beginning to define the biologic mechanisms by which phototherapy improves psoriasis.
METHODS
To provide an overview of the mechanisms thought to be responsible for the therapeutic effects of phototherapy, a review was performed on all relevant published studies in the Medline database from January 1, 1985, to August 15, 2011.
FINDINGS
Four categories of action were proposed in the literature to describe the effects of phototherapy in psoriasis: (1) alteration of the cytokine profile, (2) induction of apoptosis, (3) promotion of immunosuppression, and (4) all other mechanisms.
CONCLUSIONS
Phototherapy acts through a combination of pathways to confer therapeutic benefits in psoriasis, and these different modalities may help explain its particular usefulness in treating this cutaneous disease.
摘要
背景
光疗是治疗银屑病最有效的方法之一。新出现的研究开始确定光疗改善银屑病的生物学机制。
方法
为了全面了解光疗治疗效果的潜在机制，对 1985 年 1 月 1 日至 2011 年 8 月 15 日 Medline 数据库中所有相关的已发表研究进行了综述。
发现
文献中提出了四类作用机制来描述光疗对银屑病的影响：（1）细胞因子谱的改变，（2）诱导细胞凋亡，（3）促进免疫抑制，（4）其他所有机制。
结论
光疗通过多种途径发挥作用，为银屑病带来治疗益处，这些不同的作用模式可能有助于解释其在治疗这种皮肤疾病方面的特殊作用。
相似文献
1
Phototherapy in psoriasis: a review of mechanisms of action.
J Cutan Med Surg. 2013 Jan-Feb;17(1):6-12. doi: 10.2310/7750.2012.11124.
2
How It Works: The Immunology Underlying Phototherapy.
Dermatol Clin. 2020 Jan;38(1):37-53. doi: 10.1016/j.det.2019.08.004.
3
Current developments in phototherapy for psoriasis.
J Dermatol. 2018 Mar;45(3):287-292. doi: 10.1111/1346-8138.14213. Epub 2018 Jan 25.
4
The effects of phototherapy on the numbers of circulating natural killer cells and T lymphocytes in psoriasis.
Photodermatol Photoimmunol Photomed. 2009 Apr;25(2):109-10. doi: 10.1111/j.1600-0781.2009.00409.x.
5
Emerging Pathophysiological Targets of Psoriasis for Future Therapeutic Strategies.
Infect Disord Drug Targets. 2020;20(4):409-422. doi: 10.2174/1871526519666190617162701.
6
Advances in phototherapy for psoriasis and atopic dermatitis.
Expert Rev Clin Immunol. 2019 Nov;15(11):1205-1214. doi: 10.1080/1744666X.2020.1672537. Epub 2019 Oct 1.
7
Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease.
Adv Exp Med Biol. 2017;996:287-294. doi: 10.1007/978-3-319-56017-5_24.
8
[How to understand psoriasis?].
Rev Prat. 2004 Jan 15;54(1):28-34.
9
Phototherapy and photochemotherapy for psoriasis.
Dermatol Clin. 2015 Jan;33(1):79-89. doi: 10.1016/j.det.2014.09.007.
10
Update on the immunological mechanism of action behind phototherapy.
J Drugs Dermatol. 2014 May;13(5):564-8.
引用本文的文献
1
A Promising Approach to Psoriasis Vulgaris Management with N-Acetylcysteine and Vitamin E: Targeting the Interplay of Inflammatory and Oxidative Stress.
Biomedicines. 2025 May 22;13(6):1275. doi: 10.3390/biomedicines13061275.
2
How Cells Die in Psoriasis?
Int J Mol Sci. 2025 Apr 16;26(8):3747. doi: 10.3390/ijms26083747.
3
A complete sojourn on nanotechnological advancements and nanocarrier applications in psoriasis management.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 23. doi: 10.1007/s00210-025-03804-w.
4
The Intersection of Psoriasis and Neoplasia: Risk Factors, Therapeutic Approaches, and Management Strategies.
Cancers (Basel). 2024 Dec 18;16(24):4224. doi: 10.3390/cancers16244224.
5
Psoriasis and Lupus Erythematosus-Similarities and Differences between Two Autoimmune Diseases.
J Clin Med. 2024 Jul 25;13(15):4361. doi: 10.3390/jcm13154361.
6
Fabrication and characterization of apremilast-loaded zinc oxide-mesoporous silica nanoparticles for psoriasis treatment.
Ther Deliv. 2024;15(6):449-462. doi: 10.1080/20415990.2024.2343646. Epub 2024 May 22.
7
Emerging trends in combination strategies with phototherapy in advanced psoriasis management.
Inflammopharmacology. 2023 Aug;31(4):1761-1778. doi: 10.1007/s10787-023-01257-2. Epub 2023 Jun 16.
8
Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine.
Int J Mol Sci. 2023 Apr 11;24(8):7090. doi: 10.3390/ijms24087090.
9
Can Essential Oils/Botanical Agents Smart-Nanoformulations Be the Winning Cards against Psoriasis?
Pharmaceutics. 2023 Feb 23;15(3):750. doi: 10.3390/pharmaceutics15030750.
10
Seed Extract Inhibits AIM2-Inflammasome Activation and Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation.
Int J Mol Sci. 2023 Mar 15;24(6):5653. doi: 10.3390/ijms24065653.
本文引用的文献
1
Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation.
J Invest Dermatol. 2011 Sep;131(9):1916-26. doi: 10.1038/jid.2011.134. Epub 2011 May 26.
2
A review of phototherapy protocols for psoriasis treatment.
J Am Acad Dermatol. 2011 May;64(5):936-49. doi: 10.1016/j.jaad.2009.12.054. Epub 2011 Mar 22.
3
Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
J Invest Dermatol. 2011 Jul;131(7):1547-58. doi: 10.1038/jid.2011.53. Epub 2011 Mar 17.
4
Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis.
Br J Dermatol. 2011 Feb;164(2):344-55. doi: 10.1111/j.1365-2133.2010.10149.x.
5
Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques.
Eur J Dermatol. 2011 Jan-Feb;21(1):53-7. doi: 10.1684/ejd.2010.1199.
6
Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes.
Br J Dermatol. 2011 Apr;164(4):838-47. doi: 10.1111/j.1365-2133.2010.10169.x.
7
Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy.
Br J Dermatol. 2010 Dec;163(6):1282-90. doi: 10.1111/j.1365-2133.2010.09992.x. Epub 2010 Nov 8.
8
Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques.
J Invest Dermatol. 2010 Nov;130(11):2654-63. doi: 10.1038/jid.2010.166. Epub 2010 Jun 17.
9
8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.
J Immunol. 2010 Jun 15;184(12):7257-67. doi: 10.4049/jimmunol.0903719. Epub 2010 May 19.
10
Expression of cyclin D1 and p16 in psoriasis before and after phototherapy.
Clin Exp Dermatol. 2010 Oct;35(7):781-5. doi: 10.1111/j.1365-2230.2009.03774.x.
Zotero 插件